Cuprina Holdings (Cayman) Limited (CUPR)

Market Cap	108.32M
Revenue (ttm)	35,406
Net Income (ttm)	-1.14M
Shares Out	21.45M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	176,788
Open	4.90
Previous Close	4.92
Day's Range	4.76 - 5.42
52-Week Range	3.51 - 6.72
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CUPR

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medi...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Apr 10, 2025
• Employees: 14
• Stock Exchange: NASDAQ
• Ticker Symbol: CUPR
• Website: https://www.cuprina.com.sg

Financial Performance

In 2024, CUPR's revenue was 48,321, a decrease of -52.05% compared to the previous year's 100,773. Losses were -1.56 million, 39.4% more than in 2023.

Financial numbers in SGD